The 10 new flu-related deaths in children bring the season's total to 226, the most since 2009-10.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
One in three unvaccinated COVID-19 survivors in a Spanish cohort had no detectable SARS-CoV-2 antibodies nearly 1 year after infection, according to a prospective study published today in BMC Medicine.
After 2 years, 12% had lingering symptoms and 8% had new-onset or worsening symptoms.
The report spares no one the responsibility—including the public—for millions of preventable deaths.
South African researchers report waning monovalent (single-strain) COVID-19 vaccine booster effectiveness against the Omicron subvariants, with estimated efficacy falling to 50% against the BA.1/BA.2 and 47% against BA.4/BA.5 as early as 3 or 4 months after vaccination.
Older COVID-19 survivors may be at a 69% higher risk of developing Alzheimer's within 1 year.
In US news, practitioners describe issues with vaccination due to multiple vaccine products and confusing immunization schedules.
SARS-CoV-2 antibodies fell over time after vaccination or COVID-19 infection but were restored with booster doses in West Virginia nursing home residents and staff, and antibody levels were significantly lower during the Delta than the Omicron variant surges in those with breakthrough infections, finds a study published yesterday in JAMA Network Open.
The World Health Organization (WHO) today announced the release of the first global framework on the responsible use of life sciences, which addresses the accidental or deliberate misuse of biologic and other life sciences, including dual-use research.
A second study shows a 41% reduction in long COVID among vaccinated people.
Vaccinated people had 8 of the 10 most common long-COVID symptoms 50% to 80% less often.
